{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:18:54Z","timestamp":1771028334747,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07900"],"award-info":[{"award-number":["20K07900"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00234-022-03085-7","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T20:16:48Z","timestamp":1668457008000},"page":"569-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Regional cortical hypoperfusion and atrophy correlate with striatal dopaminergic loss in Parkinson\u2019s disease: a study using arterial spin labeling MR perfusion"],"prefix":"10.1007","volume":"65","author":[{"given":"Yuki","family":"Kitazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-0535","authenticated-orcid":false,"given":"Masamichi","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimichi","family":"Shirafuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tsujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Okazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunari","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadanori","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"3085_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397:2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"3085_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.0b013e3181ae7af1","volume":"73","author":"AH Rajput","year":"2009","unstructured":"Rajput AH, Voll A, Rajput ML et al (2009) Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 73:206\u2013212. https:\/\/doi.org\/10.1212\/WNL.0b013e3181ae7af1","journal-title":"Neurology"},{"key":"3085_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","volume":"72","author":"SM Fereshtehnejad","year":"2015","unstructured":"Fereshtehnejad SM, Romenets SR, Anang JB et al (2015) New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863\u2013873. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0703","journal-title":"JAMA Neurol"},{"key":"3085_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E De Pablo-Fern\u00e1ndez","year":"2019","unstructured":"De Pablo-Fern\u00e1ndez E, Lees AJ, Holton JL et al (2019) Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol 76:470\u2013479. https:\/\/doi.org\/10.1001\/jamaneurol.2018.4377","journal-title":"JAMA Neurol"},{"key":"3085_CR5","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1523\/jneurosci.15-03-01714.1995","volume":"15","author":"BJ Ciliax","year":"1995","unstructured":"Ciliax BJ, Heilman C, Demchyshyn LL et al (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714\u20131723. https:\/\/doi.org\/10.1523\/jneurosci.15-03-01714.1995","journal-title":"J Neurosci"},{"key":"3085_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","volume":"62","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Boer GJ et al (1997) [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62:133\u2013140. https:\/\/doi.org\/10.1136\/jnnp.62.2.133","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3085_CR7","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/mds.25975","volume":"29","author":"J Kraemmer","year":"2014","unstructured":"Kraemmer J, Kovacs GG, Perju-Dumbrava L et al (2014) Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts. Mov Disord 29:1767\u20131773. https:\/\/doi.org\/10.1002\/mds.25975","journal-title":"Mov Disord"},{"key":"3085_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1212\/01.WNL.0000149510.41793.50","volume":"64","author":"A Nagano-Saito","year":"2005","unstructured":"Nagano-Saito A, Washimi Y, Arahata Y et al (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64:224\u2013229. https:\/\/doi.org\/10.1212\/01.WNL.0000149510.41793.50","journal-title":"Neurology"},{"key":"3085_CR9","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1468-1331.2010.02980.x","volume":"17","author":"Y Nishio","year":"2010","unstructured":"Nishio Y, Hirayama K, Takeda A et al (2010) Corticolimbic gray matter loss in Parkinson\u2019s disease without dementia. Eur J Neurol 17:1090\u20131097. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.02980.x","journal-title":"Eur J Neurol"},{"key":"3085_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2016.00243","volume":"7","author":"RP Guimar\u00e3es","year":"2017","unstructured":"Guimar\u00e3es RP, Santos MCA, Dagher A et al (2017) Pattern of reduced functional connectivity and structural abnormalities in Parkinson\u2019s disease: an exploratory study. Front Neurol 7:1\u20139. https:\/\/doi.org\/10.3389\/fneur.2016.00243","journal-title":"Front Neurol"},{"key":"3085_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00259-006-0261-9","volume":"34","author":"T Eckert","year":"2007","unstructured":"Eckert T, Van Laere K, Tang C et al (2007) Quantification of Parkinson\u2019s disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging 34:496\u2013501. https:\/\/doi.org\/10.1007\/s00259-006-0261-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3085_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","volume":"34","author":"C Huang","year":"2007","unstructured":"Huang C, Mattis P, Tang C et al (2007) Metabolic brain networks associated with cognitive function in Parkinson\u2019s disease. Neuroimage 34:714\u2013723. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.09.003","journal-title":"Neuroimage"},{"key":"3085_CR13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s11604-017-0694-z","volume":"35","author":"T Maekawa","year":"2017","unstructured":"Maekawa T, Sato N, Ota M et al (2017) Correlations between dopamine transporter density measured by 123I-FP-CIT SPECT and regional gray matter volume in Parkinson\u2019s disease. Jpn J Radiol 35:755\u2013759. https:\/\/doi.org\/10.1007\/s11604-017-0694-z","journal-title":"Jpn J Radiol"},{"key":"3085_CR14","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/hbm.23130","volume":"37","author":"H Choi","year":"2016","unstructured":"Choi H, Cheon GJ, Kim HJ et al (2016) Gray matter correlates of dopaminergic degeneration in Parkinson\u2019s disease: a hybrid PET\/MR study using 18F-FP-CIT. Hum Brain Mapp 37:1710\u20131721. https:\/\/doi.org\/10.1002\/hbm.23130","journal-title":"Hum Brain Mapp"},{"key":"3085_CR15","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s00259-011-1874-1","volume":"38","author":"F Nobili","year":"2011","unstructured":"Nobili F, Arnaldi D, Campus C et al (2011) Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging 38:2209\u20132218. https:\/\/doi.org\/10.1007\/s00259-011-1874-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3085_CR16","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s00259-010-1381-9","volume":"37","author":"A Paschali","year":"2010","unstructured":"Paschali A, Messinis L, Kargiotis O et al (2010) SPECT neuroimaging and neuropsychological functions in different stages of Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging 37:1128\u20131140. https:\/\/doi.org\/10.1007\/s00259-010-1381-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3085_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/jmri.20382","volume":"22","author":"H Kimura","year":"2005","unstructured":"Kimura H, Kado H, Koshimoto Y et al (2005) Multislice continuous arterial spin-labeled perfusion MRI in patients with chronic occlusive cerebrovascular disease: a correlative study with CO 2 PET validation. J Magn Reson Imaging 22:189\u2013198. https:\/\/doi.org\/10.1002\/jmri.20382","journal-title":"J Magn Reson Imaging"},{"key":"3085_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jns.2018.09.007","volume":"394","author":"M Ikawa","year":"2018","unstructured":"Ikawa M, Kimura H, Kitazaki Y et al (2018) Arterial spin labeling MR imaging for the clinical detection of cerebellar hypoperfusion in patients with spinocerebellar degeneration. J Neurol Sci 394:58\u201362. https:\/\/doi.org\/10.1016\/j.jns.2018.09.007","journal-title":"J Neurol Sci"},{"key":"3085_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00702-017-1703-1","volume":"124","author":"ZJ Syrimi","year":"2017","unstructured":"Syrimi ZJ, Vojtisek L, Eliasova I et al (2017) Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson\u2019s disease. J Neural Transm 124:551\u2013557. https:\/\/doi.org\/10.1007\/s00702-017-1703-1","journal-title":"J Neural Transm"},{"key":"3085_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jmri.22515","volume":"33","author":"K Kamagata","year":"2011","unstructured":"Kamagata K, Motoi Y, Hori M et al (2011) Posterior hypoperfusion in parkinson\u2019s disease with and without dementia measured with arterial spin labeling MRI. J Magn Reson Imaging 33:803\u2013807. https:\/\/doi.org\/10.1002\/jmri.22515","journal-title":"J Magn Reson Imaging"},{"key":"3085_CR21","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.neuroimage.2011.10.033","volume":"59","author":"MA Fern\u00e1ndez-Seara","year":"2012","unstructured":"Fern\u00e1ndez-Seara MA, Mengual E, Vidorreta M et al (2012) Cortical hypoperfusion in Parkinson\u2019s disease assessed using arterial spin labeled perfusion MRI. Neuroimage 59:2743\u20132750. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.10.033","journal-title":"Neuroimage"},{"key":"3085_CR22","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"3085_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/RLU.0000000000001696","volume":"42","author":"I Apostolova","year":"2017","unstructured":"Apostolova I, Taleb DS, Lipp A et al (2017) Utility of follow-up dopamine transporter SPECT with 123I-FP-CIT in the diagnostic workup of patients with clinically uncertain Parkinsonian syndrome. Clin Nucl Med 42:589\u2013594. https:\/\/doi.org\/10.1097\/RLU.0000000000001696","journal-title":"Clin Nucl Med"},{"key":"3085_CR24","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25:2649\u20132653. https:\/\/doi.org\/10.1002\/mds.23429","journal-title":"Mov Disord"},{"key":"3085_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12149-018-1297-1","volume":"33","author":"MGM Rahman","year":"2019","unstructured":"Rahman MGM, Islam MM, Tsujikawa T et al (2019) Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis. Ann Nucl Med 33:14\u201321. https:\/\/doi.org\/10.1007\/s12149-018-1297-1","journal-title":"Ann Nucl Med"},{"key":"3085_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/diagnostics10050289","volume":"10","author":"MGM Rahman","year":"2020","unstructured":"Rahman MGM, Islam MM, Tsujikawa T, Okazawa H (2020) A novel automatic approach for calculation of the specific binding ratio in [I-123]FP-CIT SPECT. Diagnostics 10:1\u201311. https:\/\/doi.org\/10.3390\/diagnostics10050289","journal-title":"Diagnostics"},{"key":"3085_CR27","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/mrm.21790","volume":"60","author":"W Dai","year":"2008","unstructured":"Dai W, Garcia D, De Bazelaire C, Alsop DC (2008) Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 60:1488\u20131497. https:\/\/doi.org\/10.1002\/mrm.21790","journal-title":"Magn Reson Med"},{"key":"3085_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.braindev.2008.12.003","volume":"32","author":"T Tsujikawa","year":"2010","unstructured":"Tsujikawa T, Yoneda M, Shimizu Y et al (2010) Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev 32:143\u2013149. https:\/\/doi.org\/10.1016\/j.braindev.2008.12.003","journal-title":"Brain Dev"},{"key":"3085_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.mito.2013.09.007","volume":"13","author":"M Ikawa","year":"2013","unstructured":"Ikawa M, Yoneda M, Muramatsu T et al (2013) Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients. Mitochondrion 13:676\u2013680. https:\/\/doi.org\/10.1016\/j.mito.2013.09.007","journal-title":"Mitochondrion"},{"key":"3085_CR30","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/sj.jcbfm.9600185","volume":"26","author":"DL Thomas","year":"2006","unstructured":"Thomas DL, Lythgoe MF, van de Weerd L et al (2006) Regional variation of cerebral blood flow and arterial transit time in normal and hyperfused rat brain measured using continuous arterial spin labelling MRI. J Cereb Blood Flow Metab 26:274\u2013282. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600185","journal-title":"J Cereb Blood Flow Metab"},{"key":"3085_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/jcbfm.1987.102","volume":"7","author":"P Herscovitch","year":"1987","unstructured":"Herscovitch P, Raichle ME, Kilbourn MR et al (1987) Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. J Cereb Blood Flow Metab 7:527\u2013542. https:\/\/doi.org\/10.1038\/jcbfm.1987.102","journal-title":"J Cereb Blood Flow Metab"},{"key":"3085_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mrm.25197","volume":"73","author":"DC Alsop","year":"2015","unstructured":"Alsop DC, Detre JA, Golay X et al (2015) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 73:102\u2013116. https:\/\/doi.org\/10.1002\/mrm.25197","journal-title":"Magn Reson Med"},{"key":"3085_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","volume":"38","author":"J Ashburner","year":"2007","unstructured":"Ashburner J (2007) A fast diffeomorphic image registration algorithm. Neuroimage 38:95\u2013113. https:\/\/doi.org\/10.1016\/j.neuroimage.2007.07.007","journal-title":"Neuroimage"},{"key":"3085_CR34","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/WNR.0b013e3282ef69f9","volume":"18","author":"IU Isaias","year":"2007","unstructured":"Isaias IU, Benti R, Cilia R et al (2007) [123I]FP-CIT striatal binding in early Parkinson\u2019s disease patients with tremor vs. akinetic-rigid onset. NeuroReport 18:1499\u20131502. https:\/\/doi.org\/10.1097\/WNR.0b013e3282ef69f9","journal-title":"NeuroReport"},{"key":"3085_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nn1003","volume":"6","author":"AR Aron","year":"2003","unstructured":"Aron AR, Fletcher PC, Bullmore ET et al (2003) Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6:115\u2013116. https:\/\/doi.org\/10.1038\/nn1003","journal-title":"Nat Neurosci"},{"key":"3085_CR36","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s10072-020-05034-9","volume":"42","author":"G Donzuso","year":"2021","unstructured":"Donzuso G, Monastero R, Cicero CE et al (2021) Neuroanatomical changes in early Parkinson\u2019s disease with mild cognitive impairment: a VBM study; the Parkinson\u2019s Disease Cognitive Impairment Study (PaCoS). Neurol Sci 42:3723\u20133731. https:\/\/doi.org\/10.1007\/s10072-020-05034-9","journal-title":"Neurol Sci"},{"key":"3085_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bandc.2014.03.011","volume":"87","author":"RL Gama","year":"2014","unstructured":"Gama RL, Bruin VMS, T\u00e1vora DGF et al (2014) Structural brain abnormalities in patients with Parkinson\u2019s disease with visual hallucinations: a comparative voxel-based analysis. Brain Cogn 87:97\u2013103. https:\/\/doi.org\/10.1016\/j.bandc.2014.03.011","journal-title":"Brain Cogn"},{"key":"3085_CR38","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/mds.20923","volume":"21","author":"H Matsui","year":"2006","unstructured":"Matsui H, Nishinaka K, Oda M et al (2006) Minor depression and brain perfusion images in Parkinson\u2019s disease. Mov Disord 21:1169\u20131174. https:\/\/doi.org\/10.1002\/mds.20923","journal-title":"Mov Disord"},{"key":"3085_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2021.627356","volume":"13","author":"L Han","year":"2021","unstructured":"Han L, Lu J, Tang Y et al (2021) Dopaminergic and metabolic correlations with cognitive domains in non-demented Parkinson\u2019s disease. Front Aging Neurosci 13:1\u201310. https:\/\/doi.org\/10.3389\/fnagi.2021.627356","journal-title":"Front Aging Neurosci"},{"key":"3085_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2020.528809","volume":"14","author":"J Ivanidze","year":"2020","unstructured":"Ivanidze J, Skafida M, Pandya S et al (2020) Molecular imaging of striatal dopaminergic neuronal loss and the neurovascular unit in Parkinson disease. Front Neurosci 14:1\u20139. https:\/\/doi.org\/10.3389\/fnins.2020.528809","journal-title":"Front Neurosci"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-022-03085-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-022-03085-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-022-03085-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T07:36:14Z","timestamp":1675841774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-022-03085-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3085"],"URL":"https:\/\/doi.org\/10.1007\/s00234-022-03085-7","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective case\u2013control study was approved by the Research Ethics Committee of the University of Fukui (20170130).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This retrospective case\u2013control study was approved by the Research Ethics Committee of the University of Fukui (20170130) with a waiver of the requirement for patients\u2019 informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}